Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.55% | 78.16 | 1.0% | $1909.23m | |
| AMGN | Amgen, Inc. | 1.17% | 214.05 | 1.3% | $940.05m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.05% | 504.00 | 2.6% | $851.64m | |
| BIIB | Biogen, Inc. | 2.04% | 317.74 | 1.5% | $812.34m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 3.21% | 263.50 | 1.9% | $673.50m | |
| MRNA | Moderna, Inc. | -1.56% | 34.10 | 0.0% | $562.49m | |
| ILMN | Illumina, Inc. | 3.96% | 289.01 | 3.5% | $512.65m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.06% | 97.89 | 2.0% | $309.28m | |
| A | Agilent Technologies, Inc. | 1.65% | 75.50 | 1.6% | $233.64m | |
| INCY | Incyte Corp. | 0.00% | 85.11 | 2.5% | $212.70m | |
| EXAS | EXACT Sciences Corp. | 2.78% | 64.00 | 21.0% | $184.73m | |
| SGEN | Seattle Genetics, Inc. | 2.43% | 127.49 | 6.1% | $174.49m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.00% | 82.77 | 4.3% | $160.44m | |
| NVAX | Novavax, Inc. | -1.99% | 15.78 | 114.7% | $122.91m | |
| IMMU | Immunomedics, Inc. | 3.62% | 19.46 | 11.9% | $118.92m |
Company Profile
Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.